A Multicenter, Prospective Non-interventional Study to Evaluate the Quality of Life in Belgian Patients With CIS or RRMS in Whom Interferon Beta-1a IM Treatment Has Been Initiated

Trial Profile

A Multicenter, Prospective Non-interventional Study to Evaluate the Quality of Life in Belgian Patients With CIS or RRMS in Whom Interferon Beta-1a IM Treatment Has Been Initiated

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2015

At a glance

  • Drugs Interferon beta-1a (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms AVAIL
  • Sponsors Biogen
  • Most Recent Events

    • 16 Oct 2015 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 02 Jun 2015 Planned End Date changed from 1 Dec 2012 to 1 Dec 2015 as per ClinicalTrials.gov record.
    • 02 Jun 2015 Planned primary completion date changed from 1 Dec 2012 to 1 Sep 2015 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top